Reference
De Benedetti F, et al. Identification of optimal subcutaneous (SC) doses of tocilizumab in children with polyarticular-course juvenile idiopathic arthritis (PCJIA). Annals of the Rheumatic Diseases 76 (Suppl. 2): 396 abstr. THU0503, 15 Jun 2017. Available from: URL: http://doi.org/10.1136/annrheumdis-2017-eular.2483 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Tocilizumab. Reactions Weekly 1697, 375 (2018). https://doi.org/10.1007/s40278-018-44931-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44931-9